Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Engerix-B Immunogenicity in Adults with Type 2 Diabetes
NCT01627340Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2012
- Primary completion
- Dec 2013
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 4
01
Overview
A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Jul 2012; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01627340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01627340.